Q2 FY27 — 30 Oct 2026
AAKAAR Q2 FY27
Aakaar Medical Technologies achieved a decisive operational turnaround in H1 FY27, generating revenue from operations of ₹43.72 crores (up 72.64% YoY) and net profit of ₹3.54 crores compared to a loss of ₹0.80 crores in H1 FY26. Growth was propelled by strong adoption of imported aesthetic brands, ongoing traction in own brands (₹14.90 crores), and the rollout of the Xelix DODO clinic platform with 70+ onboarded doctors. However, profitability and liquidity were pressured by gross margin compression to 51.39% (down from 57.88% in March 2026), elevated marketing expenses of ₹3.40 crores, and de
Read the full call






